# US 2017/0253626 A1 · Functionalization and purification of molecules by reversible group exchange

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2017/0253626 A1
- Document ID: US20170253626A1
- Status: Published application
- Kind: A1
- Application number: 15/431,470
- Filed: 2017-02-13
- Published: 2017-09-07
- Earliest claimed: 2011-08-05
- Assignees: Illumina, Inc.
- Applicants: Illumina, Inc.
- Inventors: Frank J. Steemers; Kevin L. Gunderson; Kerri York; Ryan Christopher Smith
- Web page: https://patentgrep.com/patent/US20170253626A1

## CPC

- C07H 1/06: Separation; Purification
- C07D 495/04: Ortho-condensed systems
- C07H 21/00: Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
- C12N 15/1003: {Extracting or separating nucleic acids from biological samples, e.g. pure separation or isolation methods; Conditions, buffers or apparatuses therefor}
- C12Q 1/6811: Selection methods for production or design of target specific oligonucleotides or binding molecules
- C07H 1/00: Processes for the preparation of sugar derivatives
- C07H: SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS (derivatives of aldonic or saccharic acids C07C, C07D; aldonic acids, saccharic acids C07C59/105, C07C59/285; cyanohydrins C07C255/16; glycals C07D; compounds of unknown constitution C07G; polysaccharides, derivatives thereof C08B; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification C12N15/00; sugar industry C13)
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- C12N: MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA (microbiological testing media C12Q1/00)
- C12Q: MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS (immunoassay G01N33/53); COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES

## Abstract

Embodiments of the present disclosure include methods and compositions for functionalizing molecules, such as oligonucleotides, with functional groups, including polyhistidine tags useful in affinity methods. Some embodiments include methods for modifying and purifying complex mixtures of molecules by exchange of functional tags.

## Claims

### Claim 1

(canceled)

### Claim 2

A method for modifying a nucleic acid, the method comprising:
(a) contacting a sample comprising a nucleic acid with a binding partner immobilized on an affinity substrate, wherein the nucleic acid comprises a purification tag, under conditions to form a first covalent bond coupling the nucleic acid to the binding partner;
(b) separating the substrate-coupled nucleic acid from the sample, thereby isolating the nucleic acid from the sample; and
(c) performing an exchange reaction comprising contacting the nucleic acid isolated in step (b) with an exchange reagent under conditions sufficient to break the first covalent bond between the nucleic acid and the binding partner and to form a second covalent bond between the exchange reagent and the nucleic acid.

### Claim 3 (depends on 2)

The method of claim 2, wherein the first covalent bond is a —C═N— bond.

### Claim 4 (depends on 2, 3)

The method of claim 2 or claim 3, wherein the purification tag is an aldehyde and the binding partner comprises an amine moiety.

### Claim 5 (depends on 4)

The method of claim 4, wherein the amine moiety is a moiety comprising a —NHNH2 group.

### Claim 6 (depends on 4)

The method of claim 4, wherein the 5′ terminal nucleotide of the nucleic acid comprises the aldehyde purification tag.

### Claim 7 (depends on 2)

The method of claim 2, wherein the binding partner is irreversibly associated with the substrate.

### Claim 8 (depends on 2)

The method of claim 2, wherein the substrate is a bead, a magnetic bead, a paramagnetic bead, a resin, a particle, a magnetic particle, a membrane, or a gel.

### Claim 9 (depends on 2, 3)

The method of claim 2 or claim 3, wherein the second covalent bond is a —C═N— bond.

### Claim 10 (depends on 2)

The method of claim 2, wherein the exchange reagent comprises an —O—NH2 group.

### Claim 11 (depends on 2)

The method of claim 2, wherein the exchange reagent is hydroxylamine.

### Claim 12 (depends on 2)

The method of claim 2, wherein the exchange reagent comprises an —O—NH2 group and a functional tag.

### Claim 13 (depends on 12)

The method of claim 12, wherein the functional tag is selected from the group consisting of histidine, biotin, glutathione-S-transferase, a fluorophore, a radioisotope, a chromogen, an enzyme, and an epitope.

### Claim 14 (depends on 13)

The method of claim 13, wherein the functional tag is biotin.

### Claim 15 (depends on 2)

The method of claim 2, wherein the separating does not comprise high performance liquid chromatography.

### Claim 16 (depends on 2)

The method of claim 2, wherein the nucleic acid comprises DNA.

### Claim 17 (depends on 2)

The method of claim 2, wherein the sample comprises a plurality of synthesized nucleic acids comprising full-length synthesized nucleic acid molecules and partially synthesized nucleic acid molecules.
